Grant: Project Grant
Université de Montréal
$830,026.00
Discovery and characterization of novel genetic-exchange and drug-resistance mechanisms in Leishmania parasites
FY 2019-20
Summary
The leishmaniases are a group of life-threatening diseases caused by parasites transmitted by sand flies. Leishmaniases affect millions of people worldwide, leading to thousands of deaths every year. In the absence of vaccines, current control of these diseases is based in chemotherapy, which counts with a very limited arsenal threatened by the emergence and spread of drug-resistant strains. Cases of leishmaniases in Canada have a long history due to arrival of travelers, armed forces personnel, and immigrants from endemic areas. Moreover, dog imports from endemic areas represent an emerging vector for transmission of leishmaniasis to Canada. In the shadow of growing concern and treatment failure due to resistance, our team studies how parasites that have survived to antimicrobial treatments release small vesicles, named exosomes, containing unique signature motifs allowing for a rapid and accurate identification of such resistant parasites. Moreover, experiments proposed in our research project will permit to understand and characterize how exosomes could serve as shuttle vehicle for different genetic factors, some of which would have the power of transforming sensitive parasites in drug-resistant ones. Collectively, knowledge stemming from our research will likely lead to the development of novel diagnostic tools for the rapid and accurate detection, and appraisal, of antimicrobial resistance in the field, as well as better implemented therapeutic approaches against these important infectious agents.
Department
Program
Project Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
419026
Name
Fernandez Prada Christopher
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Discovery and characterization of novel genetic-exchange and drug-resistance mechanisms in Leishmania parasites
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$830,026
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Drug Resistance; Exosomes; Genetic Exchange; Leishmania; Multi-Omicapproaches; Protozoan Parasites
Abstract
The leishmaniases are a group of life-threatening diseases caused by parasites transmitted by sand flies. Leishmaniases affect millions of people worldwide, leading to thousands of deaths every year. In the absence of vaccines, current control of these diseases is based in chemotherapy, which counts with a very limited arsenal threatened by the emergence and spread of drug-resistant strains. Cases of leishmaniases in Canada have a long history due to arrival of travelers, armed forces personnel, and immigrants from endemic areas. Moreover, dog imports from endemic areas represent an emerging vector for transmission of leishmaniasis to Canada. In the shadow of growing concern and treatment failure due to resistance, our team studies how parasites that have survived to antimicrobial treatments release small vesicles, named exosomes, containing unique signature motifs allowing for a rapid and accurate identification of such resistant parasites. Moreover, experiments proposed in our research project will permit to understand and characterize how exosomes could serve as shuttle vehicle for different genetic factors, some of which would have the power of transforming sensitive parasites in drug-resistant ones. Collectively, knowledge stemming from our research will likely lead to the development of novel diagnostic tools for the rapid and accurate detection, and appraisal, of antimicrobial resistance in the field, as well as better implemented therapeutic approaches against these important infectious agents.
Competitiondate
202003
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Fernandez Prada, Christopher; Olivier, Martin
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $830,026~ $0~